MEDICUS PHARMA LTD

Medicus Pharma (MDCX) stocks dip 68% last month, now trading at $2.63—explore the clinical‑stage company’s global biotech strategy and market outlook.

Medicus Pharma stock dips 2.4%, trading around $2.45 as the company faces a 67% decline since month‑end; explore its 52‑week highs and low, market cap, and latest trading data.

Medicus Pharma (MDCX) trades near $2.54, a 66.97% decline yet a potential rebound amid clinical-stage biotech investments—see latest market insights.

Medicus Pharma (MDCX) drops 4.6% amid 68% yearly decline; stock trades at $2.51, market cap $3.6 M, 200‑day SMA $24.66. Explore latest price & trading data.